Australia markets closed

Orchestra BioMed Holdings, Inc. (OBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.95000.0000 (0.00%)
As of 04:00PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,760
2,760
3,533
-782
5,703
Cost of revenue
186
186
211
199
145
Gross profit
2,574
2,574
3,322
-981
5,558
Operating expenses
Research development
33,822
33,822
21,945
12,890
13,477
Selling general and administrative
20,258
20,258
14,034
7,928
10,833
Total operating expenses
54,080
54,080
35,979
20,818
24,310
Operating income or loss
-51,506
-51,506
-32,657
-21,799
-18,752
Interest expense
-
-
-
927
-
Total other income/expenses net
-1,463
-1,463
-1,001
-288
-2,934
Income before tax
-49,120
-49,120
-33,608
-23,014
-21,355
Income from continuing operations
-49,120
-49,120
-33,608
-23,014
-21,355
Net income
-49,120
-49,120
-33,608
-23,014
-21,355
Net income available to common shareholders
-49,120
-49,120
-33,608
-23,014
-21,355
Basic EPS
-0.91
-
-1.06
-0.73
-0.68
Diluted EPS
-0.91
-
-1.06
-0.73
-0.68
Basic average shares
31,614
-
31,614
31,614
31,614
Diluted average shares
31,614
-
31,614
31,614
31,614